Authors
Latest:
Procainamide-induced Pleural and Pericardial EffusionsDrug-induced diseases and serious adverse drug effects can alter therapeutic plans and greatly affect patient outcomes. Many medications are known to have a narrow therapeutic index and to require close patient monitoring.
Latest:
Telemedicine Offers New Hope For Burnout Reduction During COVID-19A trio of clinicians discuss what needs to occur for telemedicine to be seen as a positive in reducing burnout during the ongoing pandemic.
Latest:
Addressing Treatment Challenges and Advancing Care in PsoriasisAn examination of the physical, emotional and social burden of psoriasis, and the continued need for research to advance care for patients.
Latest:
Bilateral Acute Angle-Closure GlaucomaBilateral disease is rare but may be caused by several drug classes. Physicians need to consider these medications and other etiologies in their differential diagnosis to ensure prompt and appropriate treatment.
Latest:
Making the Grade: How Doctor-grading Websites Can Impact Your Practice, and What You Can Do to Lessen the BlowShould your practice have a policy for responding to negative comments about the quality of care and service delivered by you and your staff left anonymously on an online physician-grading website?
Latest:
Ethnic differences in blood pressure control in menWe compared blood pressure control among white and African American hypertensive men in Veterans Affairs (VA) and non-VA sites, and found that the dis parity between the two ethnic groups was 40% less at VA sites. Better access to care and medications for African Americans at the VA sites may explain the difference.
Latest:
Aspirin Therapy for Prevention of Cardiovascular Disease in Patients with DiabetesCoronary artery disease is the leading cause of death in patients with diabetes. Platelets play a major role in the pathophysiology and clinical manifestations of ischemic heart disease. It is well known that platelets in diabetic patients are hyperreactive, with exaggerated adhesion, aggregation, and thrombin generation. Aspirin and other antiplatelet agents have been shown to reduce the incidence of ischemic events in patients with and without diabetes, whether or not they have a history of cardiovascular disease. This article reviews the latest recommendations for the use of antiplatelet therapy in the primary and secondary prevention of cardiovascular events in diabetic patients.
Latest:
ASH Interview SeriesThe December issue of Oncology & Biotech News featured highlights from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition. We wrap up our ASH coverage this month with interviews on multiple myeloma with Brian G.M. Durie, MD, medical director and co-founder of the International Myeloma Foundation; chronic lymphocytic leukemia (CLL) with Robert J. Kreitman, MD, from the National Cancer Institute; and chronic myeloid leukemia (CML) with Francis J. Giles, MD, Cancer Therapy and Research Center at The University of Texas Health Science Center in San Antonio.
Latest:
Right to Try: Limited Resolve, Endless HopeLegislators and a libertarian think-tank have flaunted the merits of the Right-to-Try experimental drug policy. But physicians question its value and the message it sends to patients.
Latest:
Privacy and Security Risks and the National Health IT InfrastructureA national health information technology infrastructure (NHITI) is not only necessary, but it is cardinal to improving delivery and reducing costs of healthcare in the United States.
Latest:
For Psoriasis or Psoriatic Arthritis Patients, Symptom Severity Relates to Quality of LifePatients with psoriasis, psoriatic arthritis, or both conditions felt their quality of life decreased if they experienced condition symptoms in more parts of their body.
Latest:
Spironolactone and hyperkalemia in congestive heart failureIn 1999 Pitt and colleagues published the results of the RALES trial, an important study showing that the addition of a relatively small dose of the aldosterone antagonist spironolactone to a regimen that included angiotensin-converting enzyme (ACE) inhibitors for patients with severe congestive heart failure (NYHA Class III-IV) had a striking benefit on mortality
Latest:
White-coat hypertension and the development of sustained hypertensionFor 50 years, hypertension has been recognized as the most significant risk factor for the development of symptomatic cardiovascular disease in Western society.
Latest:
The prognostic role of metabolic syndrome after myocardial infarctionWe evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
